A

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

The Lancet Oncology

Authors 0

  1. Author list not loaded yet.

Cited by 6 stored of 132

6 results

References 3

3 results